| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 492.37B | 498.49B | 466.13B | 443.44B | 761.12B |
| Gross Profit | 265.44B | 266.18B | 244.04B | 227.61B | 201.49B |
| EBITDA | 87.69B | 90.72B | 80.46B | 66.10B | 35.78B |
| Net Income | -8.19B | 39.52B | 31.62B | 27.84B | 5.36B |
Balance Sheet | |||||
| Total Assets | 1.35T | 1.30T | 1.27T | 1.18T | 1.14T |
| Cash, Cash Equivalents and Short-Term Investments | 79.19B | 90.54B | 94.75B | 90.84B | 90.67B |
| Total Debt | 414.47B | 341.47B | 345.81B | 303.81B | 302.23B |
| Total Liabilities | 868.48B | 795.66B | 791.67B | 741.71B | 723.84B |
| Stockholders Equity | 449.79B | 473.05B | 454.08B | 413.33B | 398.57B |
Cash Flow | |||||
| Free Cash Flow | 8.60B | 43.68B | 31.68B | 10.48B | -11.89B |
| Operating Cash Flow | 53.84B | 72.49B | 59.54B | 36.50B | 21.04B |
| Investing Cash Flow | -34.92B | -39.69B | -38.50B | -10.71B | -37.12B |
| Financing Cash Flow | -31.77B | -41.77B | -20.60B | -32.43B | -4.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥1.04T | 9.13 | 9.37% | 2.59% | -1.40% | -14.78% | |
69 Neutral | ¥586.71B | 22.85 | 7.58% | 2.58% | 0.73% | -29.55% | |
66 Neutral | ¥277.39B | 2.68 | 4.97% | 2.01% | 0.87% | -38.26% | |
65 Neutral | ¥1.00T | 14.50 | 9.25% | 1.48% | -3.73% | 8.13% | |
64 Neutral | ¥1.98T | 39.08 | 17.34% | 0.72% | 16.20% | 16.84% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥549.83B | -72.11 | 9.06% | 1.84% | -1.23% | -121.69% |